EGFR and neoplasm: Direct sequencing of tumor DNA is the gold standard diagnostic method for detecting EGFR mutations, but clinical utility is limited due to its high cost, long turnaround time, and low sensitivity (limit of detection >20%; limit of detection is defined as the percentage of tumor cells that must be present in the specimen for a mutation to be identified [4]).